Approximately 30 lawsuits filed against healthcare goods manufacturer Allergan will be consolidated into a single multidistrict litigation. Plaintiffs in the lawsuits made the request to the Judicial Panel on Multidistrict Litigation over their claims that the company’s breast implant products are responsible for their development or potential development of breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL.
It’s getting harder and harder to miss the fact that there’s been a tidal shift in the perception of safety around breast implants. This shift isn’t just happening here in the United States. Women around the world are discovering that not only is there a chance of serious adverse events associated with their implants, but they may not have been told of those dangers prior to undergoing their ...